|Biochemical and biologic characterization of exosomes and microvesicles as facilitators of HIV-1 infection in macrophages|
I Kadiu, P Narayanasamy, PK Dash, W Zhang, HE Gendelman
The Journal of Immunology 189 (2), 744-754, 2012
|Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice|
PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ...
Nature communications 10 (1), 1-20, 2019
|Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice|
PK Dash, HE Gendelman, U Roy, S Balkundi, Y Alnouti, RL Mosley, ...
Aids 26 (17), 2135-2144, 2012
|Loss of neuronal integrity during progressive HIV-1 infection of humanized mice|
PK Dash, S Gorantla, HE Gendelman, J Knibbe, GP Casale, E Makarov, ...
Journal of Neuroscience 31 (9), 3148-3157, 2011
|Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India|
NB Siddappa, PK Dash, A Mahadevan, N Jayasuryan, F Hu, B Dice, ...
Journal of clinical microbiology 42 (6), 2742-2751, 2004
|Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice|
U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ...
The Journal of infectious diseases 206 (10), 1577-1588, 2012
|Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations|
P Puligujja, SS Balkundi, LM Kendrick, HM Baldridge, JR Hilaire, ...
Biomaterials 41, 141-150, 2015
|Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles|
T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ...
Biomaterials 151, 53-65, 2018
|Neuroprotective activities of CEP-1347 in models of neuroAIDS|
D Eggert, PK Dash, S Gorantla, H Dou, G Schifitto, SB Maggirwar, ...
The journal of immunology 184 (2), 746-756, 2010
|Creation of a long-acting nanoformulated dolutegravir|
B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ...
Nature communications 9 (1), 1-14, 2018
|HIV-1 Tat-mediated induction of platelet-derived growth factor in astrocytes: role of early growth response gene 1|
C Bethel-Brown, H Yao, S Callen, YH Lee, PK Dash, A Kumar, S Buch
The Journal of Immunology 186 (7), 4119-4129, 2011
|Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice|
MD Boska, PK Dash, J Knibbe, AA Epstein, SP Akhter, N Fields, R High, ...
Molecular neurodegeneration 9 (1), 1-18, 2014
|Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs|
DP Gnanadhas, PK Dash, B Sillman, AN Bade, Z Lin, DL Palandri, ...
The Journal of clinical investigation 127 (3), 857-873, 2017
|The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy|
G Zhang, D Guo, PK Dash, M Araínga, JL Wiederin, NA Haverland, ...
Nanomedicine: Nanotechnology, Biology and Medicine 12 (1), 109-122, 2016
|Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection|
AA Epstein, P Narayanasamy, PK Dash, R High, SPR Bathena, ...
Journal of Neuroimmune Pharmacology 8 (5), 1224-1238, 2013
|Development of a platelet-activating factor antagonist for HIV-1 associated neurocognitive disorders|
D Eggert, PK Dash, N Serradji, CZ Dong, P Clayette, F Heymans, H Dou, ...
Journal of neuroimmunology 213 (1-2), 47-59, 2009
|Identification of unique B/C recombinant strains of HIV-1 in the southern state of Karnataka, India|
NB Siddappa, PK Dash, A Mahadevan, A Desai, N Jayasuryan, V Ravi, ...
Aids 19 (13), 1426-1429, 2005
|Multimodal theranostic nanoformulations permit magnetic resonance bioimaging of antiretroviral drug particle tissue-cell biodistribution|
BD Kevadiya, C Woldstad, BM Ottemann, P Dash, BR Sajja, B Lamberty, ...
Theranostics 8 (1), 256, 2018
|Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype C infection|
PK Dash, NB Siddappa, A Mangaiarkarasi, AV Mahendarkar, P Roshan, ...
Retrovirology 5 (1), 1-22, 2008
|Nuclear matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling|
K Sreenath, L Pavithra, S Singh, S Sinha, PK Dash, NB Siddappa, ...
Virology 400 (1), 76-85, 2010